Variant | Gene | Disease | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
A | 0.700 | GeneticVariation | CLINVAR | ||||||||||
|
|
T | 0.700 | GeneticVariation | CLINVAR | ||||||||||
|
|
GCA | 0.700 | CausalMutation | CLINVAR | ||||||||||
|
|
G | 0.700 | GeneticVariation | CLINVAR | ||||||||||
|
|
C | 0.700 | GeneticVariation | CLINVAR | Identification of the minimal combination of clinical features in probands for efficient mutation detection in the FBN1 gene. | 19293843 | 2009 |
|||||||
|
|
C | 0.700 | GeneticVariation | CLINVAR | The importance of mutation detection in Marfan syndrome and Marfan-related disorders: report of 193 FBN1 mutations. | 17657824 | 2007 |
|||||||
|
|
C | 0.700 | CausalMutation | CLINVAR | ||||||||||
|
|
A | 0.700 | GeneticVariation | CLINVAR | ||||||||||
|
|
T | 0.700 | GeneticVariation | CLINVAR | Genetic testing of 248 Chinese aortopathy patients using a panel assay. | 27611364 | 2016 |
|||||||
|
|
T | 0.700 | GeneticVariation | CLINVAR | Fibrillin-1 misfolding and disease. | 16677079 | 2006 |
|||||||
|
|
T | 0.700 | GeneticVariation | CLINVAR | Epidermal growth factor. Location of disulfide bonds. | 4750422 | 1973 |
|||||||
|
|
G | 0.700 | GeneticVariation | CLINVAR | Latent transforming growth factor beta-binding proteins and fibulins compete for fibrillin-1 and exhibit exquisite specificities in binding sites. | 19349279 | 2009 |
|||||||
|
|
G | 0.700 | GeneticVariation | CLINVAR | The molecular genetics of Marfan syndrome and related disorders. | 16571647 | 2006 |
|||||||
|
|
G | 0.700 | GeneticVariation | CLINVAR | Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. | 17701892 | 2007 |
|||||||
|
|
G | 0.700 | GeneticVariation | CLINVAR | Marfan syndrome-causing mutations in fibrillin-1 result in gross morphological alterations and highlight the structural importance of the second hybrid domain. | 16905551 | 2006 |
|||||||
|
|
A | 0.700 | CausalMutation | CLINVAR | ||||||||||
|
|
A | 0.700 | CausalMutation | CLINVAR | ||||||||||
|
|
T | 0.700 | CausalMutation | CLINVAR | Fibrillin-1 misfolding and disease. | 16677079 | 2006 |
|||||||
|
|
T | 0.700 | CausalMutation | CLINVAR | Epidermal growth factor. Location of disulfide bonds. | 4750422 | 1973 |
|||||||
|
|
T | 0.700 | CausalMutation | CLINVAR | The solution structure of human epidermal growth factor. | 3495735 | 1987 |
|||||||
|
|
T | 0.700 | GeneticVariation | CLINVAR | ||||||||||
|
|
T | 0.700 | CausalMutation | CLINVAR | Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: distinct effects on biochemical and clinical phenotypes. | 10486319 | 1999 |
|||||||
|
|
T | 0.700 | CausalMutation | CLINVAR | Relation between genotype and left-ventricular dilatation in patients with Marfan syndrome. | 24161884 | 2014 |
|||||||
|
|
T | 0.700 | CausalMutation | CLINVAR | Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. | 17701892 | 2007 |
|||||||
|
|
T | 0.700 | CausalMutation | CLINVAR | The molecular genetics of Marfan syndrome and related disorders. | 16571647 | 2006 |